---
title: "This Biotech Stock Just Gapped Up To A Five-Year High; Here's Why"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295820138.md"
description: "On Thursday, Omeros stock reached a peak not seen in five years following exceptional second-quarter results for its latest treatment addressing transplant complications. The surge in stock value is attributed to the successful performance of the new treatment in the market."
datetime: "2026-08-13T15:10:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295820138.md)
  - [en](https://longbridge.com/en/news/295820138.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295820138.md)
generator: "portal-rs"
---

# This Biotech Stock Just Gapped Up To A Five-Year High; Here's Why

On Thursday, Omeros stock reached a peak not seen in five years following exceptional second-quarter results for its latest treatment addressing transplant complications. The surge in stock value is attributed to the successful performance of the new treatment in the market.

### Related Stocks

- [OMER.US](https://longbridge.com/en/quote/OMER.US.md)

## Related News & Research

- [Omeros VP, General Counsel Peter B. Cancelmo sells USD 927,167 of common shares](https://longbridge.com/en/news/297696692.md)
- [659,730 Shares in Omeros Corporation $OMER Bought by Corient Private Wealth LP](https://longbridge.com/en/news/297482213.md)
- [Top Omeros Executive Makes Eye-Catching Move With Insider Stock Sale](https://longbridge.com/en/news/297721007.md)
- [Omeros director Arnold C. Hanish sells USD 189,713 of common shares](https://longbridge.com/en/news/297366385.md)
- [AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 30 JUNE 2026 | SSL Stock News](https://longbridge.com/en/news/297610502.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**